相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors
Sirin Uysal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Jatin Shah et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple- negative breast cancer
Meng Lei et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
3D-QSAR-aided design, synthesis, in vitro and in vivo evaluation of dipeptidyl boronic acid proteasome inhibitors and mechanism studies
Meng Lei et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
An efficient preparation of novel epoxyketone intermediates for the synthesis of carfilzomib and its derivatives
Xiao Du et al.
JOURNAL OF CHEMICAL RESEARCH (2016)
Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) With Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results From a Phase 1b/2, Multicenter, Open-Label Study
C.P. Prada et al.
Clinical Lymphoma Myeloma & Leukemia (2015)
Proteasome Inhibitors with Pyrazole Scaffolds from Structure-Based Virtual Screening
Zachary Miller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The proteasome: mechanisms of biology and markers of activity and response to treatment in multiple myeloma
Elisabet E. Manasanch et al.
LEUKEMIA & LYMPHOMA (2014)
Increased Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma Patients Undergoing Therapy
Gayathri Ravi et al.
BLOOD (2014)
U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
Thomas M. Herndon et al.
CLINICAL CANCER RESEARCH (2013)
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia
Aldo M. Roccaro et al.
BLOOD (2010)
Synthesis, in Vitro and in Vivo Biological Evaluation, and Comprehensive Understanding of Structure-Activity Relationships of Dipeptidyl Boronic Acid Proteasome Inhibitors Constructed from β-Amino Acids
Yongqiang Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors
Yongqiang Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Design, Synthesis, Biological Evaluation, and Structure-Activity Relationship (SAR) Discussion of Dipeptidyl Boronate Proteasome Inhibitors, Part I: Comprehensive Understanding of the SAR of α-Amino Acid Boronates
Yongqiang Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
Han-Jie Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Alan L. Schwartz et al.
Annual Review of Pharmacology and Toxicology (2008)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
分享论文
